The Key to Integrated Trauma Treatment in Psychosis Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorHaukeland University Hospital
About this trial
Schizophrenia spectrum disorders (SSDs) have a significant trauma etiology: trauma has been reported in 65 - 80% in this patient group and have a negative impact on prognosis. Trauma treatment is currently not offered in SSDs due to a lack of evidence. KIT is a pragmatic trial comparing the effectiveness of added trauma focused therapy, Eye Movement Desensitization and Reprocessing (EMDR) to standard treatment in SSDs.
The study will compare EMDR as add on to treatment as usual (TAU) to TAU in patients with schizophrenia spectrum disorders (SSDs). The overall aim is to examine the effectiveness of EMDR on trauma symptoms in SSDs.
Participants will receive max. 26 sessions of EMDR, and complete assessments before, during and after the course of therapy, in addition to a period of time (6 months) after therapy to examine long-term effects.
Eligibility criteria
Qualifiers
aged ≥ 16 years
diagnosis of F20-29 in the ICD-10 assessed using SCID 5 CV
reporting trauma > 1 month prior to assessment
being currently distressed by the reported trauma(s), i.e., ≥ 5 (from 0 = not at all, to 10 = extremely) on item 21c on the Trauma and Life Events Checklist (TALE)
Disqualifiers
primary diagnosis of substance use/alcohol dependence
inability to understand spoken Norwegian
organic psychosis or a neurological disorder
hospitalized in an acute ward the last 6 weeks or
Trial design
Treatments tested in this trial
- Eye Movement Desensitization and Reprocessing (EMDR) for psychosis
Treatment groups
187 Participants
are divided into 2 treatment groupsSponsors and collaborators
Haukeland University Hospital
Lead sponsor
Helgeland Hospital Trust
Collaborator
Diakonhjemmet Hospital
Collaborator
Helse Stavanger HF
Collaborator
Helse Fonna Hospital Trust
Collaborator
University Hospital of North Norway
Collaborator
Oslo University Hospital
Collaborator
Voss DPS Bjørkeli
Collaborator
Solli DPS
Collaborator
Betanien DPS
Collaborator
St. Olavs Hospital
Collaborator
Source ClinicalTrials.gov